InvestorsHub Logo
icon url

Dr_Thorfin

01/07/16 3:19 AM

#177548 RE: John_Langston #177547

NO ONE CARES ! ! !
icon url

Couch

01/07/16 5:06 AM

#177551 RE: John_Langston #177547

Got it. Like I said no proof will be provided that Nasrat or Elite paid for any article. Why?- because they never did so and thus zero proof can be provided. You cannot provide proof for what never happened. What is left is misinformation/bs I've been hearing since .06 cents.

To imply the company has paid for an article when it hasn't is nothing more than another red herring. Particularly when proof to the counter cannot be offered up.

Here''s really what matters here is what the company has publicly stated regarding ELI 200:

The pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures. There were no serious adverse events or deaths related to ELI-200 reported during the conduct of the trial.

icon url

Dr PeteRose MLB

01/07/16 7:36 AM

#177552 RE: John_Langston #177547

Many of the articles I've read in "penny pumper" publications have disclosure statements at the end of the article stating the company featured and the form of payment, whether it be cash, stock or a combination of both. Since I've not seen this statement at the end of Elites or a few others, I can only assume that companies without the disclosure statement did not pay for the article.
I could not care less whether a company pays or not. What really matters is:
Quote:
The pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures. There were no serious adverse events or deaths related to ELI-200 reported during the conduct of the trial.


icon url

Jimmy Joe

01/07/16 2:51 PM

#177586 RE: John_Langston #177547

John where is the 2 cents per share? Market is tanking yet Elite is stable. Can you explain that to us laymen please?
Thanks LOL LOL